CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended		6 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Net revenues	$ 40,483,346	$ 14,622,656	$ 82,058,826	$ 26,994,329
Costs and expenses
Cost of services	39,096,618	12,171,183	79,336,260	22,304,188
General and administrative	5,345,742	4,455,329	10,234,926	8,291,804
Depreciation and amortization	155,937	170,555	311,204	335,213
Total costs and expenses	44,598,297	16,797,067	89,882,390	30,931,205
Loss from operations	(4,114,951)	(2,174,411)	(7,823,564)	(3,936,876)
Other (expense) income
Interest expense	(199,662)	(3,054)	(392,651)	(5,713)
Gain (loss) on change in fair value of warrant liabilities	0	511,111	0	1,333,333
Other income (expense)	54,635	10,560	93,295	12,531
Total other income (expense), net	(145,027)	518,617	(299,356)	1,340,151
Loss before benefit from income taxes	(4,259,978)	(1,655,794)	(8,122,920)	(2,596,725)
Benefit from income taxes	(26,858)	(185,040)	(56,692)	(226,593)
Net loss	(4,233,120)	(1,470,754)	(8,066,228)	(2,370,132)
Net (income) loss attributable to non-controlling interest	350,382	112,345	571,624	(303,534)
Net loss attributable to Apollo Medical Holdings, Inc.	$ (3,882,738)	$ (1,358,409)	$ (7,494,604)	$ (2,673,666)
Net loss per share:
Basic and diluted	$ (0.64)	$ (0.23)	$ (1.24)	$ (0.45)
Weighted average number of shares of common stock outstanding:
Basic and diluted	6,035,159	6,024,605	6,034,343	5,970,015